Neural network processor developer Syntiant has attracted Intel, Motorola, Robert Bosch, Applied Materials and Microsoft to a round that follows an Intel-led series A in May.

Aikucun has added $110m in series B-plus funding to its coffers, just three months after raising $87.5m in a Legend Capital-led series B round.

The drug injection device developer has reached the first close of a $50m round, with Sanofi leading the tranche and Cincinnati Children’s Hospital and Cleveland Clinic also investing.

Alexandria Venture Investments invested in the genetic drug developer, which completed a series B round that followed a $40m series A in January.

Goldman Sachs and Citi have returned to back a $20m series B round for Crux Informatics that almost doubled its overall funding to $41m.

Fuel retailer Parkland contributed to a round that lifted JF Shea-backed on-demand fuel supplier Filld’s total funding to $31m altogether.

Azur has won the support of co-founders AIG and Ascot as well as fellow insurer Hyperion to develop products targeting the high-net-worth insurance segment.

SenseTime will provide technology assistance as well as capital, having invested in IoT and AI technology provider Terminus Technologies' latest round.

The natural chemistry developer has increased its funding to $50m altogether, in a Kraft Group-backed round that will support an expansion into the textile industry.

Goldman Sachs and Galaxy Digital Ventures have joined a $15m series B extension for BitFury-backed BitGo that took the round’s total to $57.5m.